TWI426963B - Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization - Google Patents
Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization Download PDFInfo
- Publication number
- TWI426963B TWI426963B TW100114275A TW100114275A TWI426963B TW I426963 B TWI426963 B TW I426963B TW 100114275 A TW100114275 A TW 100114275A TW 100114275 A TW100114275 A TW 100114275A TW I426963 B TWI426963 B TW I426963B
- Authority
- TW
- Taiwan
- Prior art keywords
- caffeic acid
- phenylethyl alcohol
- phenethyl
- supercritical fluid
- mixture
- Prior art date
Links
- SWUARLUWKZWEBQ-VQHVLOKHSA-N phenethyl caffeate Chemical compound C1=C(O)C(O)=CC=C1\C=C\C(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-VQHVLOKHSA-N 0.000 title claims description 26
- SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 title claims description 26
- 239000012530 fluid Substances 0.000 title claims description 14
- 238000002425 crystallisation Methods 0.000 title claims description 7
- 230000008025 crystallization Effects 0.000 title claims description 7
- 239000011858 nanopowder Substances 0.000 title claims description 7
- WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 title description 9
- 238000002360 preparation method Methods 0.000 title 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 113
- 239000000203 mixture Substances 0.000 claims description 52
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 48
- 229940067107 phenylethyl alcohol Drugs 0.000 claims description 39
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 38
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 26
- 229940074360 caffeic acid Drugs 0.000 claims description 26
- 235000004883 caffeic acid Nutrition 0.000 claims description 26
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 26
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 19
- 239000001569 carbon dioxide Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- HPSGLFKWHYAKSF-UHFFFAOYSA-N 2-phenylethyl prop-2-enoate Chemical compound C=CC(=O)OCCC1=CC=CC=C1 HPSGLFKWHYAKSF-UHFFFAOYSA-N 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 11
- 238000005406 washing Methods 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 239000012296 anti-solvent Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 5
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 4
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 claims description 4
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims 4
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 10
- 238000005185 salting out Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 7
- -1 phenethyl acetonate Chemical compound 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 241000241413 Propolis Species 0.000 description 4
- 239000012527 feed solution Substances 0.000 description 4
- 229940069949 propolis Drugs 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- AMOYMEBHYUTMKJ-UHFFFAOYSA-N 2-(2-phenylethoxy)ethylbenzene Chemical compound C=1C=CC=CC=1CCOCCC1=CC=CC=C1 AMOYMEBHYUTMKJ-UHFFFAOYSA-N 0.000 description 1
- QOMFXOOKFCCSND-UHFFFAOYSA-N 2-phenylethyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCC1=CC=CC=C1 QOMFXOOKFCCSND-UHFFFAOYSA-N 0.000 description 1
- VCZXRQFWGHPRQB-UHFFFAOYSA-N CC(C)CC(C)(C)C.CC(C)CC(C)(C)C Chemical compound CC(C)CC(C)(C)C.CC(C)CC(C)(C)C VCZXRQFWGHPRQB-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 201000005787 hematologic cancer Diseases 0.000 description 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
本發明是有關於一種產製咖啡酸苯乙酯微奈米粉的方法,特別是指一種超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法。The invention relates to a method for producing phenethyl acetonate micro-nano powder, in particular to a method for producing high-purity caffeic acid phenethyl micro-nano powder by supercritical fluid anti-solvent crystallization.
咖啡酸苯乙酯(caffeic acid phenethyl ester,CAPE)是蜂膠咖啡酸的衍生物,亦是蜂膠(propolis)內生物活性重要成份之一。根據研究顯示咖啡酸苯乙酯具抗氧化能力、清除氧自由基、減少肝臟氧化的DNA損傷、抗發炎、抗病毒,及以往的一種用於治療與預防癌症之醫藥組合物(台灣發明專利公告號第561045號)所述可抑制口腔癌細胞、人類血癌細胞HL-60、淋巴癌細胞U937生長等生物活性的功效。Caffeic acid phenethyl ester (CAPE) is a derivative of propolis caffeic acid and is also one of the important biologically active components in propolis. According to research, phenethyl acetoacetate has antioxidant capacity, scavenges oxygen free radicals, reduces DNA damage caused by liver oxidation, anti-inflammatory, anti-viral, and a pharmaceutical composition for treating and preventing cancer in the past (Taiwan invention patent announcement) No. 561045) can inhibit the biological activity of growth of oral cancer cells, human blood cancer cells HL-60, and lymphoma cell line U937.
以往的一種天然物之分離方法及其分離裝置(台灣發明專利公告號第I269664號),該分離方法以天然蜂膠為原料,採用超臨界流體抗溶方式沉析咖啡酸苯乙酯成分,但需經過多數分離槽才能獲得較高的回收率,且自天然蜂膠中分離純化咖啡酸苯乙酯的成本很高,因此利用酵素合成咖啡酸苯乙酯更顯重要。目前業界多使用咖啡酸(caffeic acid,CA)與苯乙醇(phenethyl alcohol)進行酵素合成,但合成的咖啡酸苯乙酯,不易自苯乙醇中造粒,使用液相層析儀分離收集咖啡酸苯乙酯,則需耗費大量溶劑且耗時,對於環境及成本造成負擔。In the past, a method for separating natural products and a separating device thereof (Taiwan Invention Patent Publication No. I269664), the separation method uses natural propolis as a raw material, and uses a supercritical fluid anti-dissolution method to precipitate phenethyl catechol component, but The high recovery rate can be obtained by most separation tanks, and the cost of separating and purifying phenethyl acrylate from natural propolis is very high, so it is more important to synthesize phenethyl caffeate using enzymes. At present, the industry uses caffeic acid (CA) and phenethyl alcohol for enzyme synthesis, but the synthesized caffeic acid phenethyl ester is not easy to be granulated from phenylethyl alcohol. The liquid acid chromatograph is used to separate and collect caffeic acid. Phenylethyl ester requires a large amount of solvent and is time consuming, which imposes a burden on the environment and cost.
因此,本發明之目的,即在提供一種使用綠色溶劑,且可方便產製的超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法。Accordingly, it is an object of the present invention to provide a method for producing high purity caffeic acid phenethyl acrylate micronized rice by using a green solvent and conveniently producing a supercritical fluid resistant to crystallization.
於是,本發明超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法,包含下列步驟:Thus, the method for producing high-purity caffeic acid phenethyl micro-nanofine powder by supercritical fluid anti-solvent crystallization of the present invention comprises the following steps:
(i)將一溶於異辛烷及苯乙醇的酵素合成的咖啡酸苯乙酯混合物以一低溫分液處理,以獲得一第一苯乙醇混合物;(i) treating a mixture of phenethyl caffeate synthesized by an enzyme dissolved in isooctane and phenylethyl alcohol at a low temperature to obtain a mixture of first phenylethyl alcohol;
(ii)將該第一苯乙醇混合物以一超音波熱水洗處理,及一離心處理,以取得一第二苯乙醇混合物;及(ii) treating the first phenylethanol mixture with an ultrasonic hot water wash and centrifuging to obtain a second phenylethyl alcohol mixture;
(iii)將該第二苯乙醇混合物溶解於甲醇,再以一超臨界二氧化碳抗溶結晶處理,以獲得一咖啡酸苯乙酯顆粒。(iii) dissolving the second phenylethyl alcohol mixture in methanol and treating it with a supercritical carbon dioxide solution crystallization to obtain a phenethyl catenate particle.
本發明的製造方法的功效在於:藉由該超臨界二氧化碳抗溶結晶處理,可有效減少有機溶劑的使用量而產生綠色溶劑的效果,且能使該第二苯乙醇混合物中的該咖啡酸苯乙酯因過飽和而沉析形成顆粒,進而產生方便產製的效果。The effect of the manufacturing method of the present invention is that the supercritical carbon dioxide anti-solvent crystallization treatment can effectively reduce the use amount of the organic solvent to produce a green solvent, and can enable the caffeic acid benzene in the second phenylethyl alcohol mixture. The ethyl ester is precipitated by supersaturation to form particles, which in turn produces an effect of convenient production.
有關本發明之前述及其他技術內容、特點與功效,在以下配合參考圖式的一個較佳實施例的詳細說明中,將可清楚的呈現。The foregoing and other objects, features, and advantages of the invention will be apparent from the
參閱圖1,本發明超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法的一較佳實施例包含下列步驟:Referring to Figure 1, a preferred embodiment of the method for producing high purity caffeic acid phenethyl acrylate microalgae by supercritical fluid anti-solvent crystallization comprises the following steps:
步驟101是將一溶於異辛烷(2,2,4-Trimethylpentane)及苯乙醇的酵素合成的咖啡酸苯乙酯混合物以一低溫分液處理,以獲得一第一苯乙醇混合物,藉此,使該咖啡酸苯乙酯混合物與部份的異辛烷溶解於苯乙醇而形成該第一苯乙醇混合物。較佳地,該低溫分液處理的溫度為-10℃至20℃之間,處理時間為12小時至24小時之間。Step 101 is to treat a mixture of phenethyl caffeate synthesized by an enzyme dissolved in isooctane (2,2,4-Trimethylpentane) and phenylethyl alcohol at a low temperature to obtain a mixture of first phenylethyl alcohol. The mixture of phenethyl caffeate and a portion of isooctane are dissolved in phenylethyl alcohol to form the first phenethyl alcohol mixture. Preferably, the temperature of the low temperature liquid separation treatment is between -10 ° C and 20 ° C, and the treatment time is between 12 hours and 24 hours.
步驟102是將該第一苯乙醇混合物以一超音波熱水洗處理,及一離心處理,以取得一第二苯乙醇混合物,藉由該超音波熱水洗處理去除該第一苯乙醇混合物中的一咖啡酸組分。較佳地,該超音波熱水洗處理的溫度為40℃至60℃之間,處理時間為20分鐘至40分鐘之間,另,較佳地,該離心處理的轉速為10,000 rpm,處理時間為30分鐘。Step 102: treating the first phenethyl alcohol mixture with an ultrasonic hot water washing process and centrifuging to obtain a second phenylethyl alcohol mixture, and removing one of the first phenethyl alcohol mixtures by the ultrasonic hot water washing treatment. Caffeic acid component. Preferably, the temperature of the ultrasonic hot water washing treatment is between 40 ° C and 60 ° C, and the processing time is between 20 minutes and 40 minutes. Further, preferably, the centrifugal processing speed is 10,000 rpm, and the processing time is 30 minutes.
步驟103是將該第二苯乙醇混合物溶解於甲醇(methanol),再以一超臨界二氧化碳抗溶結晶處理,以獲得一咖啡酸苯乙酯顆粒。利用超臨界二氧化碳流體(carbon dioxide supercritical fluid)的抗溶劑(supercritical anti-solvent,SAS)特性,使該第二苯乙醇混合物中的咖啡酸苯乙酯因過飽和而沉析於反應槽中形成該咖啡酸苯乙酯顆粒。值得一提的是,該第二苯乙醇混合物進料濃度及進料時間,是影響該咖啡酸苯乙酯顆粒的純度及粒徑的主要變數。較佳地,該第二苯乙醇混合物進料流速為0.5 ml/min至1.0 ml/min之間,進料濃度為4 mg/ml至8 mg/ml之間。Step 103 is to dissolve the second phenylethyl alcohol mixture in methanol and then treat it with a supercritical carbon dioxide solution crystallization to obtain a phenethyl catenate particle. Using supercritical anti-solvent (SAS) characteristics of carbon dioxide supercritical fluid, the ethyl phenethyl acrylate in the second phenylethyl alcohol mixture is supersaturated and precipitated in the reaction tank to form the coffee. Acid phenethyl ester particles. It is worth mentioning that the feed concentration and feed time of the second phenylethyl alcohol mixture are the main variables affecting the purity and particle size of the phenethyl catenate particles. Preferably, the second phenylethanol mixture feed rate is between 0.5 ml/min and 1.0 ml/min and the feed concentration is between 4 mg/ml and 8 mg/ml.
以下分別透過下列具體例進一步說明本發明的製造方法。Hereinafter, the production method of the present invention will be further described by the following specific examples.
<具體例1- 超音波水洗去除咖啡酸> <Specific Example 1 - Ultrasonic washing to remove caffeic acid >
自中興大學生科中心發酵實驗室取得以酵素合成的該咖啡酸苯乙酯混合物。將該溶於異辛烷及苯乙醇的酵素合成的咖啡酸苯乙酯混合物放置-10℃冰箱中24小時後取出,用分液漏斗使其分層,收集下層的該第一苯乙醇混合物,此時,咖啡酸苯乙酯全部溶於此層。The phenethyl catecholate mixture synthesized by the enzyme was obtained from the fermentation laboratory of the ZTE University Center. The mixture of phenethyl caffeate synthesized by dissolving the enzymes of isooctane and phenylethyl alcohol was placed in a refrigerator at -10 ° C for 24 hours, and then taken out, separated by a separating funnel, and the lower first phenylolamine mixture was collected. At this time, phenethyl caffeate was all dissolved in this layer.
在定溫40℃,水與苯乙醇層體積比為30:1的條件下,以超音波進行水洗,時間為20分鐘,再以高速離心機10,000 rpm,離心30分鐘,取下層該第一次水洗的第一苯乙醇混合物,再以上述條件水洗一次後,再離心取得下層該第二次水洗的第二苯乙醇混合物。Under the condition of constant temperature 40 ° C, water and phenylethyl alcohol layer volume ratio of 30:1, ultrasonic washing was carried out for 20 minutes, and then centrifuged at 10,000 rpm for 30 minutes in a high-speed centrifuge to remove the lower layer for the first time. The water-washed first phenylethyl alcohol mixture was washed once with the above conditions, and then centrifuged to obtain the second layer of the second water-washed second phenylethyl alcohol mixture.
< HPLC分析-第一苯乙醇混合物與第二苯乙醇混合物> < HPLC analysis - mixture of first phenylethanol mixture and second phenylethyl alcohol >
參閱圖2,配置一包含咖啡酸苯乙酯與咖啡酸的標準樣品(99.8% CAPE+99.9% CA),以液相層析儀(HPLC)在325 nm波長下分析該標準樣品(圖2的a4)、該第一苯乙醇混合物(圖2的a3)、該第一次水洗的第二苯乙醇混合物(圖2的a2),及該第二次水洗的第二苯乙醇混合物(圖2的a1),並以3,4-dimethoxybenzaldehyde(I.S.)作為內標參考物,由HPLC分析圖可觀察到經過該第二次水洗的第二苯乙醇混合物中無法測得咖啡酸成份,顯示藉由該超音波熱水洗處理可以有效去除咖啡酸成分。其中,每毫升的該第一苯乙醇混合物中的苯乙醇溶有14.9mg的咖啡酸苯乙酯,且咖啡酸苯乙酯的總面積為98.3%,咖啡酸的總面積為1.1%,及總面積為0.6%的其他未知物。另,每毫升的該第二次水洗的第二苯乙醇混合物中的苯乙醇溶有159.2mg的咖啡酸苯乙酯,且咖啡酸苯乙酯總面積為99.4%。Referring to Figure 2, a standard sample containing phenethyl caffeate and caffeic acid (99.8% CAPE + 99.9% CA) was configured and analyzed by liquid chromatography (HPLC) at a wavelength of 325 nm (Figure 2 A4), the first phenethyl alcohol mixture (a3 of Figure 2), the first water-washed second phenylethyl alcohol mixture (a2 of Figure 2), and the second water-washed second phenylethyl alcohol mixture (Figure 2 A1), and using 3,4-dimethoxybenzaldehyde (IS) as an internal standard reference, it can be observed from the HPLC analysis that the caffeic acid component cannot be measured in the second phenylethanol mixture after the second water washing, which is indicated by Ultrasonic hot water washing can effectively remove caffeic acid. Wherein, the phenylethyl alcohol in the first phenethyl alcohol mixture per ml is dissolved in 14.9 mg of phenethyl caffeate, and the total area of phenethyl caffeate is 98.3%, the total area of caffeic acid is 1.1%, and total Other unknowns with an area of 0.6%. Further, the phenylethyl alcohol in the second water-washed second phenylethanol mixture per ml was dissolved in 159.2 mg of phenethyl caffeate, and the total area of phenethyl caffeate was 99.4%.
計算經該超音波熱水洗處理去除咖啡酸後的咖啡酸苯乙酯的回收率為76%。回收率=(第二苯乙醇混合物中咖啡酸苯乙酯含量/第一苯乙醇混合物中咖啡酸苯乙酯含量)×100%The recovery rate of phenethyl caffeate after removal of caffeic acid by the ultrasonic hot water washing treatment was calculated to be 76%. Recovery rate = (Phenylethyl acrylate content in the second phenylethyl alcohol mixture / phenylethyl acrylate content in the first phenylethyl alcohol mixture) × 100%
<具體例2- 超臨界二氧化碳抗溶再結晶純化該第二苯乙醇混合物中的咖啡酸苯乙酯> <Specific Example 2 - Supercritical carbon dioxide anti-solvent recrystallization to purify phenethyl catechol in the second phenylethyl alcohol mixture >
參考圖3,將定量0.152ml的該水洗二次的第二苯乙醇混合物,溶至6ml定體積甲醇溶劑,配製成4 mg/ml濃度的進料溶液,並置於量筒211內。Referring to Figure 3, 0.152 ml of this water-washed second phenylethyl alcohol mixture was metered, dissolved in 6 ml of a fixed volume of methanol solvent, and formulated into a feed solution having a concentration of 4 mg/ml, and placed in a graduated cylinder 211.
首先將二氧化碳液體從鋼瓶201內的虹吸管壓出,並外接循環水槽202降至4℃後,經由二氧化碳幫浦增壓模組203,將液態二氧化碳輸送至預熱槽204中,預熱成超臨界二氧化碳,預熱溫度由溫度控制箱205控制,其中,預熱溫度為55℃。First, the carbon dioxide liquid is pressed out from the siphon tube in the cylinder 201, and after the external circulating water tank 202 is lowered to 4 ° C, the liquid carbon dioxide is sent to the preheating tank 204 through the carbon dioxide pump pressurizing module 203, and preheated into supercritical The carbon dioxide, preheating temperature is controlled by a temperature control box 205, wherein the preheating temperature is 55 °C.
藉由觀測壓力錶206、207的壓力數值,調整背壓閥208、209承受的壓力,將沉澱槽210調整至壓力為150 bar與溫度為65℃並控制到實驗條件,再調整二氧化碳增壓模組203輸送二氧化碳的幫浦衝程頻率,調控沉澱槽210下方閥門開度,並記錄濕式流量計的累積流量,使二氧化碳流速為15L/min。By observing the pressure values of the pressure gauges 206, 207, adjusting the pressures of the back pressure valves 208, 209, the precipitation tank 210 is adjusted to a pressure of 150 bar and a temperature of 65 ° C and controlled to experimental conditions, and then the carbon dioxide supercharged mode is adjusted. Group 203 delivers the pump stroke frequency of carbon dioxide, regulates the valve opening below the settling tank 210, and records the cumulative flow rate of the wet flow meter to a carbon dioxide flow rate of 15 L/min.
等到實驗溫度、壓力、流速穩定後,將量筒211內的進料溶液以進料流速為0.5 ml/min經由過濾管212進入HPLC幫浦213內,輸送至沉澱槽210中進行抗溶結晶。沉澱槽210底部開口處214連接一個1/4”轉1/2”的管件,在內部放置1張約1cm外徑的Nylon濾紙(0.45 μm)及2張不鏽鋼網(37μm)支撐濾紙,以收集沉澱顆粒。After the experimental temperature, pressure, and flow rate were stabilized, the feed solution in the graduated cylinder 211 was introduced into the HPLC pump 213 through the filter tube 212 at a feed flow rate of 0.5 ml/min, and sent to the precipitation tank 210 for solvent-resistant crystallization. The bottom opening 214 of the sedimentation tank 210 is connected with a 1/4" to 1/2" tube, and a Nylon filter paper (0.45 μm) of about 1 cm outer diameter and two stainless steel mesh (37 μm) supporting filter paper are placed inside to collect the filter paper. Precipitate the particles.
進料溶液進入後,再泵入1.5ml甲醇溶劑並將管內剩餘的進料溶液推進沉澱槽210內,待抗溶時間到達(約3分至12分)後,關掉HPLC幫浦210,但持續輸送等溫等壓的超臨界二氧化碳150L,用以去除及乾燥沉澱槽210內殘餘溶劑。After the feed solution enters, 1.5 ml of methanol solvent is pumped in and the remaining feed solution in the tube is pushed into the precipitation tank 210. After the anti-solvent time reaches (about 3 minutes to 12 minutes), the HPLC pump 210 is turned off. However, 150 L of isothermal carbon dioxide having isothermal isostatic pressure is continuously supplied to remove and dry residual solvent in the precipitation tank 210.
最後,調整背壓閥209,將沉澱槽210壓力洩至常壓並打開過濾器,以取出濾紙。將附著在沉澱槽210管內壁的沉澱物,以HPLC幫浦213,輸送90ml的甲醇溶劑進入沉澱槽210內清洗,將洗出液減壓濃縮,並與濾紙上沉澱物合併後稱重,以計算總產率。Finally, the back pressure valve 209 is adjusted, the pressure of the sedimentation tank 210 is released to normal pressure, and the filter is opened to take out the filter paper. The precipitate adhering to the inner wall of the tube of the precipitation tank 210 is sent to the precipitation tank 210 by HPLC pump 213, and the solvent is concentrated under reduced pressure, and combined with the precipitate on the filter paper, and weighed. To calculate the total yield.
<具體例3- 超臨界二氧化碳抗溶再結晶純化該第一苯乙醇混合物中的咖啡酸苯乙酯> <Specific Example 3 - Supercritical Carbon Dioxide Anti-Soluble Recrystallization Purification of Phenylethyl Caffeate in the First Phenylethanol Mixture >
以具體例2的步驟製備該第一苯乙醇混合物中的咖啡酸苯乙酯。The phenethyl caffeate in the first phenylethyl alcohol mixture was prepared in the procedure of Specific Example 2.
< HPLC分析-咖啡酸苯乙酯沉澱物> < HPLC analysis - caffeic acid phenethyl ester precipitate >
參閱圖4,取定量咖啡酸苯乙酯沉澱物溶於1ml乙醇(ethanol)溶劑中,以高效能液相層析儀測定<具體例2>(如圖4中的a1)與<具體例3>(如圖4中的a2)中沉澱物的咖啡酸苯乙酯濃度,可觀察到<具體例2>的沉澱物無法測得咖啡酸成份。其中,該<具體例2>的沉澱物的組成是總面積為99.4%的咖啡酸苯乙酯,另該沉澱物的顆粒粒徑為69 nm。Referring to Figure 4, the phenethyl caffeate precipitate was dissolved in 1 ml of ethanol solvent and determined by high performance liquid chromatography (Specific Example 2) (a1 in Figure 4) and <Specific Example 3 In the concentration of phenethyl caffeate of the precipitate in (as in a2 of Fig. 4), it was observed that the precipitate of the specific example 2 could not measure the caffeic acid component. Here, the composition of the precipitate of the <Specific Example 2> was phenethyl caffeate having a total area of 99.4%, and the particle diameter of the precipitate was 69 nm.
計算咖啡酸苯乙酯的產率為73.5%。其中,產率=(沉澱物重量/進料重量)×100%,另,進料重量=(第二苯乙醇混合物中咖啡酸苯乙酯含量/第二苯乙醇混合物中咖啡酸苯乙酯的HPLC面積百分比)。The yield of caffeic acid phenethyl ester was calculated to be 73.5%. Wherein the yield = (precipitate weight / feed weight) × 100%, in addition, the feed weight = (the content of phenethyl acrylate in the second phenylethyl alcohol mixture / the phenethyl acrylate in the second phenylethyl alcohol mixture) HPLC area percentage).
歸納上述,本發明超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法,可獲致下述的功效及優點,故能達到本發明的目的:In summary, the method for producing high-purity caffeic acid phenethyl micro-nanofine powder by supercritical fluid anti-solvent crystallization of the present invention can attain the following effects and advantages, thereby achieving the object of the present invention:
一、藉由該超音波熱水洗處理去除該第一苯乙醇混合物中的該咖啡酸組分,以產生提高該咖啡酸苯乙酯顆粒純度的效果。1. The caffeic acid component of the first phenethyl alcohol mixture is removed by the ultrasonic hot water washing treatment to produce an effect of increasing the purity of the caffeic acid phenethyl ester particles.
二、採用該超臨界二氧化碳抗溶結晶處理,可有效減少有機溶劑的使用量,而產生使用綠色溶劑的效果。Second, the use of the supercritical carbon dioxide anti-solvent crystallization treatment can effectively reduce the amount of organic solvent used, and produce the effect of using a green solvent.
三、利用該超臨界二氧化碳抗溶結晶處理,能使該第二苯乙醇混合物中的該咖啡酸苯乙酯過飽和而沉析形成顆粒,進而產生方便產製的效果。3. The supercritical carbon dioxide anti-solvent crystallization treatment can supersaturate the caffeic acid phenethyl ester in the second phenylethyl alcohol mixture to form particles, thereby producing a convenient production system.
惟以上所述者,僅為本發明之較佳實施例而已,當不能以此限定本發明實施之範圍,即大凡依本發明申請專利範圍及發明說明內容所作之簡單的等效變化與修飾,皆仍屬本發明專利涵蓋之範圍內。The above is only the preferred embodiment of the present invention, and the scope of the invention is not limited thereto, that is, the simple equivalent changes and modifications made by the scope of the invention and the description of the invention are All remain within the scope of the invention patent.
201...鋼瓶201. . . Cylinder
202...循環水槽202. . . Circulating sink
203...幫浦增壓模組203. . . Pump booster module
204...預熱槽204. . . Preheating tank
205...溫度控制箱205. . . Temperature control box
206...壓力錶206. . . Pressure gauge
207...壓力錶207. . . Pressure gauge
208...背壓閥208. . . Back pressure valve
209...背壓閥209. . . Back pressure valve
210...沉澱槽210. . . Precipitation tank
211...量筒211. . . Measuring cylinder
212...過濾管212. . . Filter tube
213...HPLC幫浦213. . . HPLC pump
214...開口處214. . . Opening
圖1是本發明超臨界流體抗溶結晶產製高純度咖啡酸苯乙酯微奈米粉的方法的一較佳實施例的流程圖;1 is a flow chart showing a preferred embodiment of a method for producing high-purity caffeic acid phenethyl acrylate micro-nanofine powder by supercritical fluid anti-solvent crystallization according to the present invention;
圖2是一HPLC分析圖,說明一標準樣品、一第一苯乙醇混合物、一第一次水洗的第二苯乙醇混合物,及一第二次水洗的第二苯乙醇混合物的分析結果;Figure 2 is an HPLC analysis diagram showing the results of analysis of a standard sample, a first phenethyl alcohol mixture, a first water washed second phenylethyl alcohol mixture, and a second water washed second phenylethyl alcohol mixture;
圖3是該較佳實施例的一超臨界二氧化碳抗溶結晶處理的裝置示意圖;及Figure 3 is a schematic view of a device for supercritical carbon dioxide anti-solvent crystallization treatment of the preferred embodiment; and
圖4是一HPLC分析圖,說明該第一苯乙醇混合物及該第二次水洗的第二苯乙醇混合物經該超臨界二氧化碳抗溶結晶處理後的分析結果。Figure 4 is a HPLC analysis diagram showing the results of analysis of the first phenylethyl alcohol mixture and the second water-washed second phenylethyl alcohol mixture after the supercritical carbon dioxide solution crystallization treatment.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW100114275A TWI426963B (en) | 2011-04-25 | 2011-04-25 | Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW100114275A TWI426963B (en) | 2011-04-25 | 2011-04-25 | Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201242680A TW201242680A (en) | 2012-11-01 |
| TWI426963B true TWI426963B (en) | 2014-02-21 |
Family
ID=48093618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW100114275A TWI426963B (en) | 2011-04-25 | 2011-04-25 | Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI426963B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112741830A (en) * | 2021-02-09 | 2021-05-04 | 北京欧德福瑞医药科技发展有限公司 | Pharmaceutical preparation containing caffeic acid phenethyl ester raw material medicine and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1267666A (en) * | 1999-03-23 | 2000-09-27 | 贵州五倍子发展有限公司 | Supercritical CO2 extraction process of capsaicine compounds |
| TW589361B (en) * | 1997-11-07 | 2004-06-01 | Rohm & Haas | Particles and a process for preparing the same |
| TW200534875A (en) * | 2004-04-23 | 2005-11-01 | Lonza Ag | Personal care compositions and concentrates for making the same |
| US20060275219A1 (en) * | 2003-06-10 | 2006-12-07 | Taisho Pharmaceutical Co., Ltd. | Radial spherical crystallization product, process for producing the same, and dry powder preparation containing the crystallization product |
| TW200845916A (en) * | 2007-02-06 | 2008-12-01 | Fujifilm Corp | Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same |
| TW200918104A (en) * | 2007-09-07 | 2009-05-01 | Fujifilm Corp | Powder composition |
-
2011
- 2011-04-25 TW TW100114275A patent/TWI426963B/en not_active IP Right Cessation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW589361B (en) * | 1997-11-07 | 2004-06-01 | Rohm & Haas | Particles and a process for preparing the same |
| CN1267666A (en) * | 1999-03-23 | 2000-09-27 | 贵州五倍子发展有限公司 | Supercritical CO2 extraction process of capsaicine compounds |
| US20060275219A1 (en) * | 2003-06-10 | 2006-12-07 | Taisho Pharmaceutical Co., Ltd. | Radial spherical crystallization product, process for producing the same, and dry powder preparation containing the crystallization product |
| TW200534875A (en) * | 2004-04-23 | 2005-11-01 | Lonza Ag | Personal care compositions and concentrates for making the same |
| TW200845916A (en) * | 2007-02-06 | 2008-12-01 | Fujifilm Corp | Powder composition, method for producing the same, and food composition, cosmetic composition and pharmaceutical composition containing the same |
| TW200918104A (en) * | 2007-09-07 | 2009-05-01 | Fujifilm Corp | Powder composition |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201242680A (en) | 2012-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020220852A1 (en) | Method for extracting cannabidiol from cannabis sativa l. | |
| CN109970538A (en) | A class of marine fungi-derived disesquiterpenoids and their preparation method and application in the preparation of anti-inflammatory drugs | |
| CN102093175A (en) | Method for extracting quebrachitol from sapindaceae plant lychee and longan | |
| CN114315924B (en) | A kind of phenolic glycoside compound eyrein F, its preparation method and application | |
| WO2012089058A1 (en) | Crystalline form of ertapenem sodium and preparation method therefor | |
| CN102516096A (en) | Hydrochloric acid ambroxol compound and novel preparation method thereof | |
| TWI426963B (en) | Preparation of high purity caffeic acid phenethyl ester micro - nano - powder by supercritical fluid anti - crystallization | |
| CN102557918B (en) | Ibuprofen sodium compound and new preparation method thereof | |
| CN102757377B (en) | 5-hydroxytryptophan purification method as well as obtained 5-hydroxytryptophan drug | |
| CN101475444B (en) | Crude Glycerin Partial Dehydration Purification Process | |
| CN110372732B (en) | Quebracho-quinoline dimer indole alkaloid compound and application thereof | |
| CA2773177C (en) | Novel crystals of substituted phenylalkanoic acid and method of producing the same | |
| TWI406696B (en) | Supercritical Fluid Anti - Dissolution Crystallization Method for Producing High Purity of Lycium Barbarum | |
| CN103351420A (en) | Compound obtained from Momordica charantia L. through separation and preparation method and application thereof | |
| CN117801565A (en) | Green extraction method of natural wolfberry pigment and obtained product | |
| CN104402801B (en) | Method for separating DNJ and preparing DNJ nanosuspension | |
| CN118405971B (en) | Preparation method of crystal zingibenone A | |
| CN101671320B (en) | A method for separating and purifying deoxyandrographolide | |
| CN106038657A (en) | Blood activating and pain stopping tablets and preparation method thereof | |
| CN102952165A (en) | Method for extracting L-arabinose from xylose mother liquid | |
| TWI432250B (en) | Extraction of High - purity Schisandrin from Schisandra Fruit | |
| CN117720552A (en) | Longan pulp extract capable of inhibiting acetylcholinesterase and preventing and treating Alzheimer's disease as well as preparation method and application thereof | |
| CN117310049A (en) | Detection method of dioscin | |
| CN119019414A (en) | Naloxone hydrochloride impurity 1 and preparation method thereof | |
| TW201242658A (en) | Method for extracting zeaxanthin from nannochloropsis oculata |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |